Abstract
Twelve weeks of adjunctive treatment with the inhibitory neuromodulatory amino acid taurine improved psychiatric symptomatology but not cognition relative to placebo in young adult patients being treated for first‐episode psychosis, a new study has found. Researchers suggested that these results warrant further investigation of taurine in larger randomized trials.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
